MedWatch

Lundbeck makes good money off of other drug companies

Following a reorganisation of its entire production structure on a global scale, Lundbeck has built a million-dollar business from manufacturing for other companies, according to the group's EVP in charge of production.

Foto: Lundbeck/PR

In 2005 Lundbeck revamped its global production apparatus in an effort to find out what to keep and which factories to get rid of. Since then, the company has worked with LEAN manufacturing, and the combination of those two factors has ensured that Lundbeck’s production is no longer just working for Lundbeck.

“Having acquired these skills and this capacity, we asked ourselves the question if we shouldn’t start manufacturing for other pharmaceutical companies and cash in on it,” explained Lars Bang, EVP of production in Lundbeck, at last week’s drug manufacturing convention at Christiansborg (Danish parliament building), held by The Danish Association of the Pharmaceutical Industry (LIF).

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier